european association
Entity, reached from Hormuz.
- Evidence
- 55 documents · 28 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 9 Oct 2026
- Measured
- 7% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- PR Newswire · 2026-10-04 · SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026 (opens the source in a new tab)
- Medical Xpress · 2026-10-02 · Low-calorie diet and exercise put early-onset type 2 diabetes in remission for 54% of participants (opens the source in a new tab)
- The Medical News · 2026-10-01 · Real-world data reveals higher reported GLP-1 side effects in female patients (opens the source in a new tab)
- Medical Xpress · 2026-10-01 · New triple agonist drug produces substantial weight loss in diabetic patients (opens the source in a new tab)
- The Medical News · 2026-10-01 · GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes (opens the source in a new tab)
- The Medical News · 2026-10-01 · Early-onset type 2 diabetes trial demonstrates significant 24-week fat loss (opens the source in a new tab)
- Fierce Pharma · 2026-09-30 · Novo, Lilly pit their GLP-1s against one another in diabetes and obesity as EASD kicks off in Milan (opens the source in a new tab)
- The Medical News · 2026-09-28 · Research makes strong case for broader use of GLP1 drugs to protect hearts (opens the source in a new tab)
- The Medical News · 2026-09-28 · New diabetes pill orforglipron achieves uniform weight loss for women of all ages (opens the source in a new tab)
- The Medical News · 2026-09-28 · New EASD study highlights red meat sugar as independent risk factor for type 2 diabetes (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with annual meeting (29 documents)seen together
- co-mentioned with italy (27 documents)seen together
- co-mentioned with glp-1 (25 documents)seen together
- co-mentioned with easd (22 documents)seen together
- co-mentioned with eli lilly (18 documents)seen together
- co-mentioned with europe (13 documents)seen together
- co-mentioned with fda (13 documents)seen together
- co-mentioned with adverse events (12 documents)seen together
- co-mentioned with hba1c (10 documents)seen together
- co-mentioned with china (9 documents)seen together